ID   HCCM-5MTXr
AC   CVCL_W857
DR   Wikidata; Q54881840
RX   PubMed=4039287;
CC   Population: Japanese.
CC   Doubling time: ~72 hours (PubMed=4039287).
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M687 ! HCCM-5
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 10
//
RX   PubMed=4039287; DOI=10.1016/0090-8258(85)90231-8;
RA   Sekiya S., Kaiho T., Takamizawa H.;
RT   "Development of methotrexate-resistant human choriocarcinoma cells in
RT   culture.";
RL   Gynecol. Oncol. 21:46-53(1985).
//